.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Teva
Fish and Richardson
UBS
McKesson
Daiichi Sankyo
Queensland Health
Johnson and Johnson
Moodys
Deloitte

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020591

« Back to Dashboard

NDA 020591 describes TARKA, which is a drug marketed by Abbvie and is included in one NDA. It is available from three suppliers. Additional details are available on the TARKA profile page.

The generic ingredient in TARKA is trandolapril; verapamil hydrochloride. There are ten drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the trandolapril; verapamil hydrochloride profile page.

Summary for 020591

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 020591

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TARKA trandolapril; verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 020591 NDA AbbVie Inc. 0074-3287 0074-3287-13 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0074-3287-13)
TARKA trandolapril; verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 020591 NDA AbbVie Inc. 0074-3288 0074-3288-13 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0074-3288-13)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength2MG;180MG
Approval Date:Oct 22, 1996TE:ABRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength4MG;240MG
Approval Date:Oct 22, 1996TE:ABRLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength1MG;240MG
Approval Date:Oct 22, 1996TE:ABRLD:Yes

Expired Orange Book Patents for NDA: 020591

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
AbbvieTARKAtrandolapril; verapamil hydrochlorideTABLET, EXTENDED RELEASE;ORAL020591-002Oct 22, 1996► Subscribe► Subscribe
AbbvieTARKAtrandolapril; verapamil hydrochlorideTABLET, EXTENDED RELEASE;ORAL020591-003Oct 22, 1996► Subscribe► Subscribe
AbbvieTARKAtrandolapril; verapamil hydrochlorideTABLET, EXTENDED RELEASE;ORAL020591-002Oct 22, 1996► Subscribe► Subscribe
AbbvieTARKAtrandolapril; verapamil hydrochlorideTABLET, EXTENDED RELEASE;ORAL020591-004Oct 22, 1996► Subscribe► Subscribe
AbbvieTARKAtrandolapril; verapamil hydrochlorideTABLET, EXTENDED RELEASE;ORAL020591-001Oct 22, 1996► Subscribe► Subscribe
AbbvieTARKAtrandolapril; verapamil hydrochlorideTABLET, EXTENDED RELEASE;ORAL020591-004Oct 22, 1996► Subscribe► Subscribe
AbbvieTARKAtrandolapril; verapamil hydrochlorideTABLET, EXTENDED RELEASE;ORAL020591-001Oct 22, 1996► Subscribe► Subscribe
AbbvieTARKAtrandolapril; verapamil hydrochlorideTABLET, EXTENDED RELEASE;ORAL020591-003Oct 22, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Medtronic
Daiichi Sankyo
Cipla
Cantor Fitzgerald
Citi
Farmers Insurance
Dow
US Army
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot